Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by macman1519on Jan 30, 2018 2:52pm
30 Views
Post# 27464955

RE:RE:Where is Patient #4 6month results?

RE:RE:Where is Patient #4 6month results?Yes, two or three low cost treatments a year, cancer progression stopped, bladder saved, nothing much there, best to go on to other things, market is definitely unimpressed, says the scumbag!!!!!!! See how subtle is the lying going on here!!!! Has long been on my scumbag list. DONT GET U WRONG?????? DONT WORRY WE KNOW EXACTLY WHERE U R COMING FROM!!!!
2b7f6fab wrote: Probably safe to assume #4 experienced recurrence or the stock would be $1USD, and we would of heard about it already. Therefore unless some of the remaining patients have no recurrence there won't be a Ph2 unless another entity is willing to sponsor us. IMO maybe best to go after one of the other indications in a Ph1. Something where more definitive results can be demonstrated. Don't misunderstand me. I think the results to date for this Ph1 have been stellar, certainly much better than removing some ones bladder. Tld1433 2 or 3 times a year seems preferable to eventual bladder removal. It's just that so far the market thinks otherwise given the 22 cent share price.
Mickey2 wrote: Roger sleeping at the switch?





Bullboard Posts